The Hong Kong office of Debevoise & Plimpton has advised Capital Group in its acquisition of an equity stake in Intas Pharmaceuticals Limited (“Intas”), one of…
Capital Group’s $107 Million Investment in Intas Pharmaceuticals

The Hong Kong office of Debevoise & Plimpton has advised Capital Group in its acquisition of an equity stake in Intas Pharmaceuticals Limited (“Intas”), one of…
You must be a Standard 1 Year member to access this content.
…
You must be a Standard 1 Year member to access this content.